Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Comparison of hepatic elimination of different forms of cholecystokinin in dogs. Bioassay and radioimmunoassay comparisons of cholecystokinin-8-sulfate and -33-sulfate.
T Sakamoto, … , G H Greeley Jr, J C Thompson
T Sakamoto, … , G H Greeley Jr, J C Thompson
Published January 1, 1985
Citation Information: J Clin Invest. 1985;75(1):280-285. https://doi.org/10.1172/JCI111686.
View: Text | PDF
Research Article

Comparison of hepatic elimination of different forms of cholecystokinin in dogs. Bioassay and radioimmunoassay comparisons of cholecystokinin-8-sulfate and -33-sulfate.

  • Text
  • PDF
Abstract

The influence of hepatic transit on the ability of exogenous cholecystokinin-8-sulfate and -33-sulfate (CCK-8 and CCK-33, respectively) to stimulate gallbladder contraction and exocrine pancreatic secretion, as well as on the peripheral plasma concentration of each agent, was evaluated in five conscious dogs with pancreatic and gallbladder fistulas and complete portacaval transposition. The gallbladder pressure increments after portal administration of CCK-8 (0.125, 0.25, 0.50, and 1.0 microgram/kg per h for 5 min) were diminished by 36, 45, 39 and 25%, respectively, in comparison with those obtained with systemic administration of identical doses of CCK-8 (P less than 0.05). In a subsequent experiment, the integrated pancreatic juice volume, bicarbonate, and protein secretion were diminished by 22, 32, and 48%, respectively, during a 30-min infusion of CCK-8 (0.10 micrograms/kg per h) into the portal venous system, in comparison with the results obtained with systemic administration of CCK-8 (P less than 0.05). In contrast, the gallbladder pressure and pancreatic exocrine secretory responses to portal administration of CCK-33 did not differ significantly (P greater than 0.05) from the results obtained with systemic administration of CCK-33. Radioimmunoassay for CCK-8 in plasma showed that the integrated CCK-8 value during portal administration was significantly lower (P less than 0.05) than it was during systemic administration. The results for CCK-33, however, did not vary, whether it was given by a systemic or portal route (P greater than 0.05). Thus, the present study demonstrates that CCK-8 is partially inactivated by the liver whereas CCK-33 is not, which suggests that CCK-3 in the circulation may play a significant role in the physiologic regulation of the gallbladder and exocrine pancreas.

Authors

T Sakamoto, M Fujimura, J Newman, X G Zhu, G H Greeley Jr, J C Thompson

×

Total citations by year

Year: 2014 2011 2008 2007 2006 2001 2000 1999 1997 1995 1994 1993 1991 1990 1989 1988 1987 1986 1964 Total
Citations: 2 3 1 1 1 1 2 1 3 1 2 2 1 3 2 1 4 2 1 34
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (34)

Title and authors Publication Year
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects
M Acalovschi
World journal of gastroenterology : WJG 2014
Ileal interposition attenuates the satiety responses evoked by cholecystokinin-8 and -33
SA Metcalf, MC Washington, TA Brown, CS Williams, AD Strader, AI Sayegh
Peptides 2011
The feeding responses evoked by cholecystokinin are mediated by vagus and splanchnic nerves
TA Brown, MC Washington, SA Metcalf, AI Sayegh
Peptides 2011
The short term satiety peptide cholecystokinin reduces meal size and prolongs intermeal interval
DM Lateef, MC Washington, AI Sayegh
Peptides 2011
Cholecystokinin-33 is more effective than cholecystokinin-8 in inhibiting food intake and in stimulating the myenteric plexus and dorsal vagal complex
MS Cooper, JR Reeve, MO Abdalla, L Moyer, SJ Raboin, GM Green, AI Sayegh
Brain Research 2008
The cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1/3, 2, and 5/6
JF Rehfeld, JR Bundgaard, J Hannibal, X Zhu, C Norrbom, DF Steiner, L Friis-Hansen
Endocrinology 2007
Physiology of the Gastrointestinal Tract
DJ Drucker
Physiology of the Gastrointestinal Tract 2006
Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver
MG Ismair, B Stieger, V Cattori, B Hagenbuch, M Fried, PJ Meier, GA Kullak-Ublick
Gastroenterology 2001
Molecular Forms of Cholecystokinin in Human Bile in Patients with Obstructive Jaunice
A TAKAHASHI, S TANAKA, H YOSHIDA, S NAKAMATA, F NOZU, I NAKANO, K KITAMURA, T IMAMURA, A IKEGAMI, J NIIKAWA, K MITAMURA
The Showa University Journal of Medical Sciences 2000
Cholecystokinin in Acute Alcoholic and Biliary Pancreatitis
S Räty, J Sand, E Kemppainen, S Laine, I Nordback
International Journal of Gastrointestinal Cancer 2000
Cholecystokinin in the early course of acute post-ERCP pancreatitis
S Räty, J Sand, S Laine, A Harmoinen, I Nordback
Journal of the American College of Surgeons 1999
Gastric and gall bladder emptying of a mixed meal are not coordinated in liver cirrhosis--a simultaneous sonographic study
M Acalovschi, DL Dumitraşcu, I Csakany
Gut 1997
Prolonged intestinal afferent nerve discharge in response to cholecystokinin-58 compared to cholecystokinin-8 in rats
M Kreis
Neuroscience Letters 1997
Impairment of hepatic transport processes in perfused rat liver by the specific CCK receptor antagonist loxiglumide
K Beckh, A Dirks, I Koop, H Koop, G Adler
Research in Experimental Medicine 1997
Absorption of Orally Administered Enzymes
ML Gardner, KJ Steffens
1995
Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors
SP Povoski, W Zhou, DS Longnecker, RT Jensen, SA Mantey, RH Bell
Gastroenterology 1994
The Molecular Nature of Cholecystokinin in Plasma: An in vivo Immunosorption Study in Rabbits
JF Rehfeld
Scandinavian Journal of Gastroenterology 1994
Physiology and Pathophysiology of Gallbladder Motility
S Tierney, HA Pitt, KD Lillemoe
Surgical Clinics of North America 1993
Pancreatic trophism in experimental liver cirrhosis
I Nagy, F Hajnal, G Mohácsi, J Németh, Z Lászik, Á Pap
International Journal of Gastrointestinal Cancer 1993
Bile acids in human plasma interfere with cholecystokinin bioassay using dispersed pancreatic acini
K Miyasaka, A Funakoshi, M Matsumoto, R Nakamura, S Sakamoto, H Sakai, K Kitani
Digestive Diseases and Sciences 1991
Cholecystokinin and Glucose-Induced Insulinaemia in Dogs With and Without Pancreatic Acinar Atrophy
RH Meister, IH Berger, PO Schwille
Clinical Chemistry and Laboratory Medicine 1990
Cholecystokinin binding and degradation by isolated rat liver cells
MM Wolfe, M Bougoulias, JE McGuigan
Regulatory Peptides 1990
Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man
MC Jebbink, JB Jansen, AA Masclee, CB Lamers
British Journal of Clinical Pharmacology 1990
Pharmacokinetics and organ catabolism of cholecystokinin octapeptide in pigs
JC Cuber, C Bernard, T Gibard, JA Chayvialle
Regulatory Peptides 1989
Gastrointestinal Peptides
DW Green, G Gomez, GH Greeley
Gastroenterology Clinics of North America 1989
Cholecystokinin cleavage to cholecystokinin-octapeptide in vivo and in vitro: Accelerated cleavage in acute pancreatitis
CJ Springer, J Calam
Gastroenterology 1988
Plasma cholecystokinin-octapeptide like immunoreactivity in patients with hepatic cirrhosis
S Kanayama, S Himeno, Y Higashimoto, Y Yamasaki, T Kitani, S Tarui
Life Sciences 1987
A High Pressure Liquid Chromatography-Radioimmunoassay Method for Measurement of Cholecystokinin-8 and Cholecystokinin-33/39 in Plasma
EJ Draviam, GH Greeley, RD Beauchamp, JC Thompson
Journal of Liquid Chromatography 1987
The Biosynthesis of Regulatory Peptides
GJ Dockray
American journal of respiratory and critical care medicine 1987
Effect of synthetic trypsin inhibitor on plasma immunoreactive cholecystokinin in rats
S Kanayama, S Himeno, Y Yamasaki, Y Shinomura, T Kitani, S Tarui
Gastroenterologia Japonica 1987
Stand und Gegenstand chirurgischer Forschung
FW Eigler, HJ Peiper, FW Schildberg, J Witte, V Zumtobel
1986
Inactivation of cholecystokinin octapeptide by normal and cirrhotic liver in rats
Z Berger, Á Pap, I Ungi, V Varro
International Journal of Gastrointestinal Cancer 1986
Advances in Metabolic Disorders
G Aurbach, JT Potts
Advances in Metabolic Disorders 1964

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts